Eton Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ETON
CUSIP
29772L108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 29772L108 since 12/18/2024, largest first.

Filer % of Class Filed
Opaleye Management Inc. 13G/A
8.5% 11/6/2026
Event 9/30/2026
EcoR1 Capital, LLC 13G/A
7.7% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G/A 6.9% 7/28/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 131 5.79 M $298M
2026 Q2 164 20.0 M $723M
2026 Q1 116 17.8 M $439M
2025 Q4 105 16.4 M $277M
2025 Q3 104 18.2 M $398M
2025 Q2 89 17.1 M $243M
2025 Q1 87 14.6 M $190M
2024 Q4 73 13.6 M $182M
2024 Q3 50 10.0 M $60.0M
2024 Q2 46 8.72 M $28.7M
2024 Q1 45 7.67 M $28.8M
2023 Q4 57 7.65 M $33.5M
2023 Q3 53 6.90 M $28.8M
2023 Q2 34 5.98 M $20.9M
2023 Q1 36 5.84 M $22.5M
2022 Q4 33 5.94 M $18.2M
2022 Q3 33 6.34 M $14.4M
2022 Q2 31 5.92 M $17.7M
2022 Q1 34 5.78 M $27.4M
2021 Q4 33 5.73 M $27.1M
2021 Q3 38 5.96 M $32.6M
2021 Q2 48 6.84 M $51.8M
2021 Q1 52 8.79 M $68.0M
2020 Q4 48 8.73 M $75.0M
2020 Q3 40 7.04 M $59.5M
2020 Q2 42 6.80 M $39.8M
2020 Q1 18 5.97 M $24.5M
2019 Q4 15 2.62 M $18.9M
2019 Q3 15 2.28 M $14.4M
2019 Q2 11 1.77 M $14.0M
2019 Q1 13 1.50 M $12.0M
2018 Q4 13 1.15 M $7.05M